Advanced search
Publication Cover
Modern Rheumatology Volume 28, 2018 - Issue 3
Journal homepage
329
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

The efficacy of abatacept focusing on anti-CCP antibody in Japanese patients with rheumatoid arthritis for 104 weeks

Takeshi MochizukiDepartment of Orthopaedic Surgery, Kamagaya General Hospital, Japan; Correspondence[email protected]
,
Koichiro YanoInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan;
,
Katsunori IkariInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan;
,
Ryo HiroshimaDepartment of Orthopaedic Surgery, Kamagaya General Hospital, Japan;
,
Kosei KawakamiDepartment of Orthopaedic Surgery, Kamagaya General Hospital, Japan;
,
Naoko KoenumaDepartment of Orthopaedic Surgery, Kamagaya General Hospital, Japan;
,
Mina IshibashiDepartment of Orthopaedic Surgery, Kamagaya General Hospital, Japan;
&
Shigeki MomoharaDepartment of Orthopaedic Surgery, Keio University, Tokyo, Japan
 show all
Pages 575-577 | Received 02 Nov 2016, Accepted 31 Jul 2017, Published online: 24 Aug 2017
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Conflict of interest

T. M. received honorarium for the lecture from AbbVie, Inc., Asahi Kasei Pharma Corp., Bristol-Myers Squibb Co., Chugai Pharmaceutical Co., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan Co., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., and Takeda Pharmaceutical Co., Ltd. K. Y. received honorarium for the lecture from Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Santen Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd. K. I. received honorarium for the lecture and/or unrestricted research grants from AbbVie, Inc., Asahi Kasei Pharma Corp., Astellas Pharma Inc., Bristol-Myers Squibb Co., Chugai Pharmaceutical Co., Eisai Co., Ltd. Hisamitsu Pharmaceutical Co. Inc., Janssen Pharmaceutical K.K., Kaken Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Co., Santen Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Co. Ltd. and Takeda Pharmaceutical Co., Ltd. S. M. received honorarium for the lecture and/or unrestricted research grants from AbbVie, Inc., Asahi Kasei Pharma Corp., Bristol-Myers Squibb Co., Chugai Pharmaceutical Co., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Co., Nakashima Medical Co., Ltd., Santen Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Co. Ltd. and Takeda Pharmaceutical Co., Ltd. The other authors declare that they have no conflicts of interest.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.